Business & People, Manufacturers & Providers
US FDA has agreed to undertake a priority review of Takeda's ixazomib
FDA approved to prioritize the status of a New Drug Aplication.
In an unexpected move, just before the end of 2011, ...
Improving expenditure efficiency has been, for a ver...
Your Portal Link to Mass Media Universe.
Valuable Quarterly Romanian Market Analysis.
Ask the analyst
Tailor-made advice for you